CAR-T cells, which are genetically programmed to specifically recognize and kill target cells, have altered the therapeutic ...

A model developed by LMU biophysicists demonstrates how biological processes form the convoluted internal architecture of the ...

Cells once thought passive are now seen as sculptors. Their choreography may explain how tissues form and fail. A new study ...

Capstan Therapeutics scientists demonstrate that lipid nanoparticles can engineer CAR T cells within the body without ...

Tarlatamab improved PFS and OS over chemotherapy as second-line treatment in patients with SCLC in the phase 3 DeLLphi-304 trial.

T-cell therapy has been a game changer in the treatment of B-cell malignancies, although their manufacturing process is complex and needs lymphodepletion, thus limiting their use. Researchers from ...

† Department of Chemistry and Chemistry Institute for Functional Materials, Pusan National University, Busan 609-735, Republic of Korea ‡ Advanced Materials Division, Korea Research Institute of ...

Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted ...

Trials enrolling patients with relapsed leukemia, lymphoma and brain cancers, respectively, report early data showing ...

Researchers present a new method to safely and preferentially generate CAR T cells directly inside the body using targeted lipid nanoparticles that deliver mRNA directly to T cells.

At Miami-Dade’s public hospital system Jackson Health, new advancements in genetic research recently helped doctors modify a ...

In the field of cancer immunotherapy, unconventional T cells (UCTs) and Chimeric Antigen Receptor (CAR) T cells have emerged as promising areas of research ...